NAMS
Newamsterdam Pharma Company N.v.
Netherlands-based biopharmaceutical company developing therapies for metabolic diseases
CUSIP: N62509109HealthcareNL1 holder
Total Value
$189.78M
Total Shares
8.02M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$189.78M8.02M sharesUnchanged